MiSight® 1 day contact lenses are turning heads, including in mainstream media. Fortune magazine recently dubbed CooperVision “one to watch” in an article exploring MiSight® 1 day as a “purpose-built option” to both correct an age-appropriate* child’s vision and potentially slow the progression of their myopia.†[i]
Through interviews with eye care professionals, researchers and other industry experts, the article reveals several key takeaways including:
- MiSight® 1 day can be a practice builder and encourage referrals, according to MiSight® 1 day fitters Dr. Ashley Wallace-Tucker and Dr. Dave Anderson.
- Education is key. Growing parent awareness and understanding of childhood myopia and how it’s treated is an essential part of getting children with myopia the treatment they need.
- There’s more to come. There is still much to be done to address the myopia epidemic and CooperVision is dedicated to continued innovation.
[i] Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
*Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to 4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
†Compared to a single vision 1 day lens over a 3-year period